280 related articles for article (PubMed ID: 17338649)
1. Treatment of acute myeloid leukemia in older patients.
Roboz GJ
Expert Rev Anticancer Ther; 2007 Mar; 7(3):285-95. PubMed ID: 17338649
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia.
Roboz GJ; Ritchie EK; Curcio T; Provenzano J; Carlin R; Samuel M; Wittenberg B; Mazumdar M; Christos PJ; Mathew S; Allen-Bard S; Feldman EJ
Cancer; 2008 Nov; 113(9):2504-11. PubMed ID: 18825661
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid leukemia treatment in patients over 60 years of age. Comparison of symptomatic, palliative, and aggressive therapy.
Doubek M; Palasek I; Brychtova Y; Buchtova I; Mayer J
Neoplasma; 2005; 52(5):411-4. PubMed ID: 16151586
[TBL] [Abstract][Full Text] [Related]
4. [Elderly patients with acute myeloid leukemia: characteristics in biology, patients, and treatment].
Wedding U; Bokemeyer C; Meran JG; ; ;
Med Klin (Munich); 2003 Apr; 98(4):193-207. PubMed ID: 12715143
[TBL] [Abstract][Full Text] [Related]
5. Emerging treatments in acute myeloid leukaemia.
Kell J
Expert Opin Emerg Drugs; 2004 May; 9(1):55-71. PubMed ID: 15155136
[TBL] [Abstract][Full Text] [Related]
6. Treatment of childhood acute myeloid leukemia.
ter Bals E; Kaspers GJ
Expert Rev Anticancer Ther; 2005 Oct; 5(5):917-29. PubMed ID: 16221060
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia.
Malfuson JV; Etienne A; Turlure P; de Revel T; Thomas X; Contentin N; Terré C; Rigaudeau S; Bordessoule D; Vey N; Gardin C; Dombret H;
Haematologica; 2008 Dec; 93(12):1806-13. PubMed ID: 18838471
[TBL] [Abstract][Full Text] [Related]
8. Limited value of FLT3 mRNA expression in the bone marrow for prognosis and monitoring of patients with acute myeloid leukemia.
Kainz B; Fonatsch C; Schwarzinger I; Sperr WR; Jäger U; Gaiger A
Haematologica; 2005 May; 90(5):695-6. PubMed ID: 15921390
[TBL] [Abstract][Full Text] [Related]
9. General approach to, and perspectives on clinical research in, older patients with newly diagnosed acute myeloid leukemia.
Estey EH
Semin Hematol; 2006 Apr; 43(2):89-95. PubMed ID: 16616042
[TBL] [Abstract][Full Text] [Related]
10. Molecular characteristics therapy in AML.
Radich GP
Clin Adv Hematol Oncol; 2009 Jun; 7(6):11-4. PubMed ID: 19645131
[No Abstract] [Full Text] [Related]
11. Clinical trials in adult AML.
Stock W
Clin Adv Hematol Oncol; 2009 Jun; 7(6):8-10. PubMed ID: 19645130
[No Abstract] [Full Text] [Related]
12. Survival of elderly patients with acute myeloid leukemia.
Pulsoni A; Pagano L; Latagliata R; Casini M; Cerri R; Crugnola M; De Paoli L; Di Bona E; Invernizzi R; Marmont F; Petti MC; Rigolin G; Ronco F; Spadano A; Tosti ME; Visani G; Mele A; Mandelli F
Haematologica; 2004 Mar; 89(3):296-302. PubMed ID: 15020267
[TBL] [Abstract][Full Text] [Related]
13. Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia.
Baz R; Rodriguez C; Fu AZ; Jawde RA; Kalaycio M; Advani A; Sobecks R; Sekeres MA
Cancer; 2007 Oct; 110(8):1752-9. PubMed ID: 17724726
[TBL] [Abstract][Full Text] [Related]
14. [Acute myeloid leukemia].
Miyazaki Y; Kuriyama K
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1192-8. PubMed ID: 11579629
[TBL] [Abstract][Full Text] [Related]
15. Treatment of acute myeloid leukaemia in younger patients.
Burnett AK
Best Pract Res Clin Haematol; 2001 Mar; 14(1):95-118. PubMed ID: 11355926
[TBL] [Abstract][Full Text] [Related]
16. Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?
Ferrara F
Hematol Oncol; 2014 Mar; 32(1):1-9. PubMed ID: 23512815
[TBL] [Abstract][Full Text] [Related]
17. Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia.
Qian SX; Li JY; Tian T; Shen YF; Jiang YQ; Lu H; Wu HX; Zhang SJ; Xu W
Leuk Res; 2007 Oct; 31(10):1383-8. PubMed ID: 17420048
[TBL] [Abstract][Full Text] [Related]
18. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
[TBL] [Abstract][Full Text] [Related]
19. Strategies in the treatment of acute myeloid leukemia.
Lowenberg B
Haematologica; 2004 Sep; 89(9):1029-32. PubMed ID: 15377460
[No Abstract] [Full Text] [Related]
20. Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemia.
Kalaycio M; Advani A; Pohlman B; Sekeres M; Tripp B; Rybicki L; Sobecks R
Am J Hematol; 2008 Nov; 83(11):831-4. PubMed ID: 18756545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]